Article Details

AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study

Retrieved on: 2021-05-22 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study. View article details on hiswai:

Excerpt

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the ...

Article found on: wap.business-standard.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up